BioSpace News Archive

The WEB® Aneurysm Embolization System is the first intrasaccular flow disruptor PMA approved for the embolization of wide neck bifurcation aneurysms

SpendEdge, a well-known procurement intelligence solution provider, has announced the completion of their latest inventory management study for a medical equipment manufacturer.

National Partners in Healthcare (NPH) is pleased to announce Mike Saunders, CPA is joining the leadership team as the President, CEO and Board member.

Phigenics announces the introduction of their new enterprise and facility information management system, phiAnalytics™.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval of STELARA® (ustekinumab) for the treatment of adults withmoderately to severely active ulcerative colitis (UC).

B3C newswire / -- Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that it has entered into a collaboration agreement with BioMed X Innovation Center, Heidelberg.

Senseonics Holdings, Inc. today announced the appointment of Jon D. Isaacson as the company’s Chief Financial Officer, effective immediately.

Malin Corporation plc (ISE:MLC), a company investing in highly innovative life sciences companies, today notes that its investee company Poseida Therapeutics, Inc. (“Poseida”), a clinical-stage biotechnology company based in San Diego, California, has filed a registration statement on Form S-1 (“Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering (“IPO”) in the United States of shares of Poseida’s common stock

Skyland Analytics today announced its release of Skyland PIMS™ v3.0 with the latest CRC™ (Charting, Reporting & Compliance) module. New capabilities include segmented control charts, process capability, and additional analytical features.

McKesson Corporation will release financial results for its third fiscal quarter ended